Showing reports 21 - 30 of 172 in category :
Cancer Nanotechnology Plan | |
Source: NCI Alliance for Nanotechnology in Cancer – Publication date: July 2004 | |
The CNPlan describes how to accelerate the application of nanotechnology to cancer research and clinical care, emphasizing the need for cross-disciplinary and cross-sector collaboration to develop and deliver the public health benefits. | |
Carbon nanotubes - Exposure, toxicology and protective measures in the work environment | |
Source: Swedish Work Environment Authority – Publication date: November 2011 | |
This summary overview of current knowledge is a compilation of literature in the field of carbon nanotubes and deals with occupational exposure, toxicology and protective measures used in the work environment. | |
Cellulose Nanomaterials - A Path Towards Commercialization | |
Source: U.S. Department of Agriculture – Publication date: August 2014 | |
The U.S. Forest Service has released a report that details the pathway to commercializing affordable, renewable, and biodegradable cellulose nanomaterials from trees. Cellulosic nanomaterials are tiny, naturally occurring structural building blocks and hold great promise for many new and improved commercial products. | |
Characterising the potential risks posed by engineered nanoparticles | |
Source: UK Department for Environment, Food and Rural Affairs (Defra) – Publication date: November 2005 | |
This report published by the UK Government Department of Environment, Food and Rural Affairs (Defra) outlines the UK's research objectives to characterise the potential risks posed by engineered free nanoparticles and funding mechanisms to address these. | |
Characterising the Potential Risks posed by Engineered Nanoparticles - 2nd report | |
Source: UK Government – Publication date: December 2007 | |
The Government has now published it's second research report Characterising the Potential Risks posed by Engineered Nanoparticles. This report builds on the 2005 report and 2006 progress report, providing an update on the Defra's Nanotechnology Research Co-ordination Group�??s objectives and associated programme of work. | |
Chemical Industry R&D Roadmap for Nanomaterials By Design | |
Source: Chemical Industry Vision 2020 – Publication date: December 2003 | |
Preliminary results from Chemical Industry Vision 2020 Technology Partnership's Nanomaterials and the Chemical Industry R&D Roadmap Workshop | |
Closing the gap: The impact of nanotechnologies on the global divide | |
Source: Nanotechnology Industries Association – Publication date: November 2013 | |
In light of debates that make nanotechnologies responsible for a further widening of the aforementioned divide, the Nanotechnology Industries Association (NIA) has published a report analysing this Nano-Gap, or Nano-Divide, by examining the pros and cons of nanotechnologies and their impact global development and the on-going fight against poverty. | |
Communicating Nanotechnology in Europe | |
Source: European Commission – Publication date: May 2010 | |
The European Commission has compiled a roadmap for communicating nanotechnology across Europe. It presents the focus, objectives, methodology and actions already in place and to be developed over the next few years. The 188-page document is structured into three main parts: Where are we now? Where do we want to be? and How do we get there? and provides a detailed overview of all relevant activities and initiatives existing or planned across Europe. | |
Compendium of Projects in the European NanoSafety Cluster (2012 edition) | |
Source: NanoSafetyCluster – Publication date: February 2012 | |
This is the third edition of the Nanosafety Cluster compendium. It documents the status of important projects on nanomaterial toxicity and exposure monitoring, integrated risk management, research infrastructure and coordination and support activities. | |
Concept for a European Infrastructure in Nanobiotechnology | |
Source: EuroNanoBio – Publication date: January 2010 | |
The EuroNanoBio partners explored the definition, establishment and further development of a European scale infrastructure on nanobiotechnology and the associated realistic implementation plan. It aimed at defining not only the key features of a potential European infrastructure in nanobiotechnology, but it has also established the way it should be designed. | |